Cargando…
Lipid-Based Drug Delivery Systems for Diseases Managements
Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495957/ https://www.ncbi.nlm.nih.gov/pubmed/36140237 http://dx.doi.org/10.3390/biomedicines10092137 |
_version_ | 1784794150097387520 |
---|---|
author | Gbian, Douweh Leyla Omri, Abdelwahab |
author_facet | Gbian, Douweh Leyla Omri, Abdelwahab |
author_sort | Gbian, Douweh Leyla |
collection | PubMed |
description | Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and large-scale manufacturing of liposomes as delivery systems are deeply discussed. The benefits, toxicity, and limitations of the use of liposomes in pharmacotherapeutics including in diagnostics, brain targeting, eye and cancer diseases, and in infections are provided. The experimental approaches that may reduce, or even bypass, the use of liposomal drug drawbacks is described. The application of liposomes in the treatment of numerous diseases is discussed. |
format | Online Article Text |
id | pubmed-9495957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94959572022-09-23 Lipid-Based Drug Delivery Systems for Diseases Managements Gbian, Douweh Leyla Omri, Abdelwahab Biomedicines Review Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active agents. The description of the physicochemical properties, formulation methods, characteristics, mechanisms of action, and large-scale manufacturing of liposomes as delivery systems are deeply discussed. The benefits, toxicity, and limitations of the use of liposomes in pharmacotherapeutics including in diagnostics, brain targeting, eye and cancer diseases, and in infections are provided. The experimental approaches that may reduce, or even bypass, the use of liposomal drug drawbacks is described. The application of liposomes in the treatment of numerous diseases is discussed. MDPI 2022-08-31 /pmc/articles/PMC9495957/ /pubmed/36140237 http://dx.doi.org/10.3390/biomedicines10092137 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gbian, Douweh Leyla Omri, Abdelwahab Lipid-Based Drug Delivery Systems for Diseases Managements |
title | Lipid-Based Drug Delivery Systems for Diseases Managements |
title_full | Lipid-Based Drug Delivery Systems for Diseases Managements |
title_fullStr | Lipid-Based Drug Delivery Systems for Diseases Managements |
title_full_unstemmed | Lipid-Based Drug Delivery Systems for Diseases Managements |
title_short | Lipid-Based Drug Delivery Systems for Diseases Managements |
title_sort | lipid-based drug delivery systems for diseases managements |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495957/ https://www.ncbi.nlm.nih.gov/pubmed/36140237 http://dx.doi.org/10.3390/biomedicines10092137 |
work_keys_str_mv | AT gbiandouwehleyla lipidbaseddrugdeliverysystemsfordiseasesmanagements AT omriabdelwahab lipidbaseddrugdeliverysystemsfordiseasesmanagements |